⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMRX News
Amneal Pharmaceuticals, Inc. Class A Common Stock
Zambon anuncia a aprovação de Hopledo®, por parte da Comissão Europeia, um medicamento para adultos com doença de Parkinson e flutuações motoras moderadas a graves
businesswire.com
AMRX
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations
businesswire.com
AMRX
Zambon annuncia l’approvazione da parte della Commissione Europea di Hopledo® per pazienti adulti con Malattia di Parkinson e fluttuazioni motorie da moderate a severe
businesswire.com
AMRX
Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines
globenewswire.com
ABBV
AMGN
AZN
BMY
ROG
GILD
GSK
JNJ
LLY
MRK
NVS
SNY
PFE
JAZZ
AMRX
Carboprost Tromethamine Market to Reach USD 2.79 Billion by 2031 as Postpartum Hemorrhage Treatment Demand Rises
globenewswire.com
PFE
RDY
TEVA
AMRX
SUN
GLAD
Global Lenalidomide Market to Reach USD 20.85 Billion by 2031, Advancing at a 5.39% CAGR
globenewswire.com
BMY
TEVA
RDY
CI
NAT
AMRX
SUN
VTRS
Dyspnea Treatment Market 2026-2031 - Rising Prevalence of Respiratory and Cardiovascular Diseases to Drive Growth
globenewswire.com
PFE
AZN
TEVA
AMRX
BHC
Babesiosis Treatment 2026-2031 - Rising Incidence of Tick-Borne Diseases Drives Market Growth
globenewswire.com
AMRX
GSK
PFE
VTRS
Form 8-K
sec.gov
AMRX
Form 8-K
sec.gov
AMRX